Abbott Laboratories Reports Strong Q2 Earnings, Raises Full-Year Guidance
Abbott Laboratories (ABT) reported second-quarter comparable sales growth of 4.8% and adjusted earnings per share of $1.31, exceeding expectations. The company raised its full-year adjusted EPS guidance to a range of $5.45 to $5.60 due to improved margins and strong performance in medical devices and diagnostics.
Tickers: $ABT
Topics: adjusted_eps financial_results guidance_update sales_growth